(testicular cancer ony)

Slides:

Advertisements

Similar presentations

Breast Cancer (C50): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

Advertisements

Cancer Waiting Times, UK countries England Wales Scotland

(cervical cancer only)

Mesothelioma (C45): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

Bladder Cancer (C67): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 53.5% 66.5% 63.6% patients treated for cancer.

Eye Cancer (C69): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

Sarcoma: Cancer Waiting Times, UK countries England Wales

Uterine Cancer (C54-C55): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Females, UK Northern.

Cancer of Unknown Primary (C77-C80): 2013

Head & Neck Cancer (C00-C14, C30-C32): 2014

Haematological Cancers:

Bone Cancer (C40-C41): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 53.4% 50.0% 51.7% patients treated for.

Prostate Cancer (C61): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Males, UK Northern England.

Liver Cancer (C22): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Upper Gastrointestinal Cancers:

Breast Cancer (C50): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 87.5% 83.3% 87.4% patients treated for cancer.

Hodgkin Lymphoma (C81): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 34.2% 43.8% 39.2% patients treated for.

Lung Cancers: Cancer Waiting Times, UK countries England

Cancer Waiting Times, UK countries England Wales Scotland

Age-Standardised Ten-Year Net Survival for the Most Common Cancers in Males, England and Wales, Ten-year survival for is predicted.

Uterine Cancer (C54-C55): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Females, UK Northern.

In Situ Breast Carcinoma (D05): 2014

Lower Gastrointestinal Cancers:

Breast Cancer: Cancer Waiting Times, UK countries

Non-Melanoma Skin Cancer (C44): 2014

Laryngeal Cancer (C32): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 47.1% 51.0% 50.3% patients treated for.

Stomach Cancer (C16): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 39.0% 51.7% 48.0% patients treated for cancer.

Lung Cancer (C33-C34): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Kidney Cancer (C64-C66,C68): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England.

Bone Sarcoma (C40-C41): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

per 100,000 Population, Females, UK

Liver Cancer (C22): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 42.2% 57.1% 52.8% patients treated for cancer.

Ovarian Cancer (C56-C57.4): 2014 Cancer Patient Experience Survey, Females, England Female Percentage of 47.0% patients treated for cancer who visited.

Eye Cancer (C69): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 86.4% 76.6% 80.9% patients treated for cancer.

Malignant Melanoma (C43): 2014

Chronic Myeloid Leukaemia (C92.1): 2014

Kidney Cancer (C64-C66,C68): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 53.5% 62.2% 59.2% patients treated.

Oral Cancer (C00-C06,C09-C10,C12-C14): 2014

Hodgkin Lymphoma (C81): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Bowel Cancer (C18-C20): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Oesophageal Cancer (C15): 2014

Non-Hodgkin Lymphoma (C82-C86): 2014

Myeloma (C90): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Chronic Lymphocytic Leukaemia (C91.1): 2014

Lung Cancer (C33-C34): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 50.3% 51.4% 50.9% patients treated for.

Prostate Cancer (C61): 2014 Cancer Patient Experience Survey, Males, England Male Percentage of 51.9% patients treated for cancer who visited their GP.

Acute Myeloid Leukaemia (C92. 0, C92. 4, C92. 5, C92. 6, C92. 8, C93

Myeloma (C90): 2014 Cancer Patient Experience Survey, by Sex, England

Penile Cancer (C60): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Males, UK Northern England.

Bladder Cancer (C67): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Anal Cancer (C21): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Pancreatic Cancer (C25): 2014

per 100,000 Population, Females, UK

Eye Cancer (C69): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Leukaemia (C91-C95): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Acute Lymphoblastic Leukaemia (C91.0): 2014

Prostate Cancer (C61): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Males, UK Northern England.

Gallbladder Cancer (C23): 2014

Cancer of Unknown Primary (C77-C80): 2014

Acute leukaemia: Cancer Waiting Times, UK countries England

Ovarian Cancer (C56-C57.4): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Females, UK Northern.

Pancreatic Cancer (C25): 2014

Breast Cancer (C50): 2014 Numbers of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Scotland.

Stomach Cancer (C16): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Gallbladder Cancer (C23): 2014

Thyroid Cancer (C73): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Laryngeal Cancer (C32): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Haematological Cancers:

Anal Cancer (C21): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 45.9% 60.8% 50.9% patients treated for cancer.

Brain, Other CNS and Intracranial Tumours (C70-C72, C75. 1-C75

Presentation transcript:

(testicular cancer ony) Urological Cancers: 2014-2015 Cancer Waiting Times, UK countries England Wales Scotland Northern Ireland (testicular cancer ony) 14 day wait: seen by specialist following referral Performance 94.3% 97.0% Standard 93% Performance against standard Meets standard 31 day wait: receipt of first treatment following decision to treat 95.3% 91.9% 94.0% 90.8% 89.7% 96% 98% 95% Does not meet standard 62 day wait: receipt of first treatment following referral 78% 85.5% 85.9% 56.1% 85% Data for 14 day and 31 wait in England also for testicular cancer separately. Codes vary per country but cancer waiting times data group 'Urological cancer' broadly includes: penis, prostate, testis, other and unspecified male genital organs, kidney, renal pelvis, ureter, bladder, other and unspecified urinary organs, secondary cancers of kidney, renal pelvis, bladder and other and unspecified urinary organs. See source for more information. Source: cruk.org/cancerstats You are welcome to reuse this Cancer Research UK statistics content for your own work. Credit us as authors by referencing Cancer Research UK as the primary source. Suggested style: Cancer Research UK, full URL of the page, Accessed [month] [year].